In the previous study, the downregulated genes CASP10 and CD177 and the upregulated genes BAK1, ST14, CD82, and MUC4 were detected as biomarkers for lung cancer by the joint sparse regression model (Loxham and Davies, 2017). This evidence concerns the gene CD82 and lung cancer.